Setback for AZ’ asthma drug as trial misses endpoint
AstraZeneca’s tralokinumab has failed to significantly reduce the rate of annual exacerbations in patients with uncontrolled asthma taking part in a late-stage trial.
Read More
Tag: IL-13
NIHR partners with AstraZeneca on asthma study
The National Institute for Health Research and AstraZeneca have formed a new partnership aiming to progress “crucial research” in respiratory disease.
Read More
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
